Remove Arkansas Remove Community Remove Marketing Remove Regional
article thumbnail

Excited To Help People

Independent Banker

In Arkansas, Jim S. Central Region Award Recipient. Once he gets his mind set, a plan forms and then becomes a very calculated reality,” offers Tara Salinas, the bank’s marketing and business development officer. In rural communities like ours, the consumer has a lot of needs,” he explains. Jim Gowen Sr. Newport, Ark.

St. Louis 105
article thumbnail

Top 5 Total Return to Shareholders: #4 Bank of the Ozarks

Jeff For Banks

But he held firm that the regulatory environment, changing customer preferences, and the pace and expense of technology were driving the market towards bigger is better. Neither supported this regional president''s opinion. Collectively, the management team built an Arkansas franchise rivaling the largest banks in the state.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Acquire or Be Acquired 2018: Breaks, Bulls and Business Models

Gonzobanker

At the same time, most bank executives agreed that a 20%-25% increase in earnings from the tax break is being earmarked for investments in their franchises: market expansion, raises for employees and, of course, technology investments. Prosperity is now $22 billion with an unbelievable $5 billion market cap. Source: Federal Reserve.

Taxes 75
article thumbnail

Top 5 Total Return to Shareholders: #3 ESB Financial Corporation

Jeff For Banks

But he held firm that the regulatory environment, changing customer preferences, and the pace and expense of technology were driving the market towards bigger is better. Neither supported this regional president''s opinion. Last post was dedicated to the #4 Bank, Bank of the Ozarks of Little Rock, Arkansas (see post here ).

article thumbnail

The AI Industry Series: Top Healthcare AI Trends To Watch

CB Insights

In the private market, healthcare AI startups have raised $4.3B It was given a “breakthrough device designation” to expedite the process of bringing the product to market. Apart from use by the FDA to monitor post-marketing drug safety, RWE can help design better clinical trials and new treatments in the future. of the time.